These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 16314543)

  • 1. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
    Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
    Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
    Mora S; Rifai N; Buring JE; Ridker PM
    Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
    Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
    Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
    Goodson NJ; Symmons DP; Scott DG; Bunn D; Lunt M; Silman AJ
    Arthritis Rheum; 2005 Aug; 52(8):2293-9. PubMed ID: 16052597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study.
    Best LG; Zhang Y; Lee ET; Yeh JL; Cowan L; Palmieri V; Roman M; Devereux RB; Fabsitz RR; Tracy RP; Robbins D; Davidson M; Ahmed A; Howard BV
    Circulation; 2005 Aug; 112(9):1289-95. PubMed ID: 16116058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
    Onat A; Can G; Hergenç G
    Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation biomarkers and near-term death in older men.
    Jenny NS; Yanez ND; Psaty BM; Kuller LH; Hirsch CH; Tracy RP
    Am J Epidemiol; 2007 Mar; 165(6):684-95. PubMed ID: 17215383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
    Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
    Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
    Albert MA; Glynn RJ; Buring J; Ridker PM
    Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum C-reactive protein and risk of cardiovascular events in middle-aged and older chinese population.
    Jiang S; Bao Y; Hou X; Fang Q; Wang C; Pan J; Zuo Y; Zhong W; Xiang K; Jia W
    Am J Cardiol; 2009 Jun; 103(12):1727-31. PubMed ID: 19539083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population.
    Romero-Corral A; Sierra-Johnson J; Lopez-Jimenez F; Thomas RJ; Singh P; Hoffmann M; Okcay A; Korinek J; Wolk R; Somers VK
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):418-25. PubMed ID: 18431365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study.
    van der Meer IM; de Maat MP; Kiliaan AJ; van der Kuip DA; Hofman A; Witteman JC
    Arch Intern Med; 2003 Jun; 163(11):1323-8. PubMed ID: 12796068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study.
    Laaksonen DE; Niskanen L; Nyyssönen K; Punnonen K; Tuomainen TP; Salonen JT
    Eur Heart J; 2005 Sep; 26(17):1783-9. PubMed ID: 15821003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of conventional and novel mechanisms in explaining increased risk of cardiovascular events in offspring with positive parental history.
    Hamer M; Chida Y; Stamatakis E
    J Hypertens; 2009 Oct; 27(10):1966-71. PubMed ID: 19587606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.